Laboratoire HP2, Institut National de la Santé et de la Recherche Médicale, U1300, Université Grenoble Alpes, Grenoble, France.
Laboratoire Exploration Fonctionnelle Cardio-Respiratoire (EFCR), Centre Hospitalier Universitaire Grenoble Alpes (CHUGA), Grenoble, France.
Ann Am Thorac Soc. 2024 May;21(5):814-822. doi: 10.1513/AnnalsATS.202312-1077OC.
Oral appliances are second-line treatments after continuous positive airway pressure for obstructive sleep apnea (OSA) management. However, the need for oral appliance titration limits their use as a result of monitoring challenges to assess the treatment effect on OSA. To assess the validity of mandibular jaw movement (MJM) automated analysis compared with polysomnography (PSG) and polygraphy (PG) in evaluating the effect of oral appliance treatment and the effectiveness of MJM monitoring for oral appliance titration at home in patients with OSA. This observational, prospective study included 135 patients with OSA eligible for oral appliance therapy. The primary outcome was the apnea-hypopnea index (AHI), measured through in-laboratory PSG/PG and MJM-based technology. Additionally, MJM monitoring at home was conducted at regular intervals during the titration process. The agreement between PSG/PG and MJM automated analysis was revaluated using Bland-Altman analysis. Changes in AHI during the home-based oral appliance titration process were evaluated using a generalized linear mixed model and a generalized estimating equation model. The automated MJM analysis demonstrated strong agreement with PG in assessing AHI at the end of titration, with a median bias of 0.24/h (limits of agreement, -11.2 to 12.8/h). The improvement of AHI from baseline in response to oral appliance treatment was consistent across three evaluation conditions: in-laboratory PG (-59.6%; 95% confidence interval, -59.8% to -59.5%), in-laboratory automated MJM analysis (-59.2%; -65.2% to -52.2%), and at-home automated MJM analysis (-59.7%; -67.4% to -50.2%). Incorporating MJM automated analysis into the oral appliance titration process has the potential to optimize oral appliance therapy outcomes for OSA.
口腔矫治器是阻塞性睡眠呼吸暂停(OSA)管理中持续气道正压通气的二线治疗方法。然而,由于监测挑战限制了其使用,需要对口腔矫治器进行滴定以评估其对 OSA 的治疗效果。
本观察性前瞻性研究纳入了 135 名符合口腔矫治器治疗条件的 OSA 患者。主要结局指标是通过实验室多导睡眠图/多导睡眠描记术(PSG/PG)和多导生理记录仪(PG)以及基于下颌运动(MJM)的技术自动分析评估口腔矫治器治疗效果的睡眠呼吸暂停低通气指数(AHI)。此外,在滴定过程中定期进行家庭 MJM 监测。使用 Bland-Altman 分析重新评估 PSG/PG 和 MJM 自动分析之间的一致性。使用广义线性混合模型和广义估计方程模型评估家庭口腔矫治器滴定过程中 AHI 的变化。
自动 MJM 分析在评估滴定结束时的 AHI 方面与 PG 具有很强的一致性,中位偏差为 0.24/h(一致性界限为-11.2 至 12.8/h)。口腔矫治器治疗后 AHI 从基线的改善在三种评估条件下是一致的:实验室 PG(-59.6%;95%置信区间,-59.8%至-59.5%)、实验室自动 MJM 分析(-59.2%;-65.2%至-52.2%)和家庭自动 MJM 分析(-59.7%;-67.4%至-50.2%)。
将 MJM 自动分析纳入口腔矫治器滴定过程中有可能优化 OSA 的口腔矫治器治疗效果。